Embody biological processes
Leader in bio-integrative technology
Endless product pipeline
It is understood that products come from early ideas that need to be nurtured before development. It is expected that Gel-Del Foundation, a non-profit entity, will provide mechanisms to achieve exciting new technological advances and medical products that would otherwise be difficult to pursue. For example, university faculty studying cell-protein interactions of Gel-Del material with government grants or other funding discover a stem cell application as a potential life saving treatment. Although there are many hurdles, the shepherding and business relationships with Gel-Del Companies will help such early stage discoveries to proceed into product development.
Since Gel-Del subsidiaries focus on separate markets, a pipeline of future products are needed in many areas. Therefore, there needs to be a focus on pre-product technologies. By encouraging interactions with non-profit and government institutions, and their faculty, Gel-Del Foundation will be the first step in bringing licensed technologies forward that have commercial potential. Next, Gel-Del Technologies will help further the technology and develop the products to make them ready for manufacture at a Gel-Del Company. Although it is envisioned that primary technology developments will involve Gel-Del patents and technology from its already broad array of intellectual property, all early stage ideas will certainly be nurtured and incorporated into the Gel-Del portfolio.
Gel-Del Foundation is not a charity and does not make donations. Gel-Del Foundation only engages in joint programs with non-profit entities that have a material transfer agreement with Gel-Del Technologies, Inc.